Citius Pharmaceuticals, Inc. Secures $3.8 million through New Jersey Economic Development Program

Citius Pharmaceuticals, Inc. Secures $3.8 million through New Jersey Economic Development Program [Accessibility Statement] Skip NavigationNon-dilutive capital supports continued execution and value creationCRANFORD, N.J., Feb. 24, 2026 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today announced that the Company has received $3.8 million ...